Detailed Analysis: Painkiller Labeling Review and Design Strategies

This report provides a comprehensive review of a painkiller label, specifically focusing on the Omega Pain Relieving Liniment. It begins by outlining the essential information that a painkiller label should communicate, including batch numbers, manufacturing and expiry dates, and product costs. The report then examines the design of the label, highlighting how it caters to consumer needs by providing crucial information. Furthermore, the report incorporates recommendations for improving label design, such as including details about potential side effects and ensuring the clarity of manufacturing and expiry dates to prevent potential health hazards. The report emphasizes the importance of accurate and easily accessible information for consumers to ensure safe and effective use of the medication, referencing relevant literature to support its arguments.

Running head: Review The Labeling Of A Painkiller Or Cold Medication
REVIEW THE LABELING OF A PAINKILLER OR COLD
MEDICATION

2
Review The Labeling Of A Painkiller Or Cold Medication
Table of Contents
Purpose of Communication.............................................................................................................3
Purpose Served by Designs on Labels.............................................................................................3
Recommendations of Design Strategies..........................................................................................4

3
Review The Labeling Of A Painkiller Or Cold Medication
Purpose of Communication
The painkiller, whose label has been chosen to be reviewed, is Omega Pain Relieving Liniment.
Figure 1: Label of Omega Pain Relieving Liniment
(Source: drugs.com, 2010)
The basic of communication of a painkiller label is to provide information regarding the
following requirements:
 Batch number of the product
 Manufacturing date of the product
 Expiry date of the product
 Cost of the product
 Facts with regard to drugs that were used in the manufacture of this painkiller
This service of provision of information should be provided for all those to whom this drug has
been prescribed to be used.
Purpose Served by Designs on Labels
The design, that is made use of by most labels of painkillers, is such that information only for
things that are not always read by consumers. The design serves audience by making only one
thing known to them. According to Ellison, Lusk & Davis (2014), this one thing is that basic
information is always looked up for by consumers before purchasing any drug or any such
perishable product.

4
Review The Labeling Of A Painkiller Or Cold Medication
Recommendations of Design Strategies
According to Dendler (2014), labels need to consist of such various unexpected details that
consumers may not think that would have been included. This is because consumers will find it a
lot easier to consume such a drug that provides details about various pros and cons that can take
place if intake of this drug is increased or decreased. Manufacturing and expiry dates need to
never be smudged (Brach, Walsh & Shaw, 2017). This is because it needs to be known by
consumers about dates after which consumption of the drug needs to be stopped. Not stopping
the consumption of any drug after tits expiry date will lead to terrible consequences. This is
because drugs are organic and can be deadly is consumed after it has gone bad.

5
Review The Labeling Of A Painkiller Or Cold Medication
Reference List
Brach, S., Walsh, G., & Shaw, D. (2017). Sustainable consumption and third-party certification
labels: Consumers’ perceptions and reactions. European Management Journal.
Dendler, L. (2014). Sustainability Meta Labelling: an effective measure to facilitate more
sustainable consumption and production?. Journal of Cleaner Production, 63, 74-83.
Ellison, B., Lusk, J. L., & Davis, D. (2014). The effect of calorie labels on caloric intake and
restaurant revenue: evidence from two full-service restaurants. Journal of Agricultural
and Applied Economics, 46(2), 173-191.